These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 10858196

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.
    Hervas-Stubbs S, Majlessi L, Simsova M, Morova J, Rojas MJ, Nouzé C, Brodin P, Sebo P, Leclerc C.
    Infect Immun; 2006 Jun; 74(6):3396-407. PubMed ID: 16714570
    [Abstract] [Full Text] [Related]

  • 24. Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.
    Cheung GY, Xing D, Prior S, Corbel MJ, Parton R, Coote JG.
    Infect Immun; 2006 Dec; 74(12):6797-805. PubMed ID: 16982827
    [Abstract] [Full Text] [Related]

  • 25. The adenylate cyclase of Bordetella pertussis: a vector to target antigen presenting cells.
    El Azami El Idrissi M, Ladant D, Leclerc C.
    Toxicon; 2002 Dec; 40(12):1661-5. PubMed ID: 12457876
    [No Abstract] [Full Text] [Related]

  • 26. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
    Macdonald-Fyall J, Xing D, Corbel M, Baillie S, Parton R, Coote J.
    Vaccine; 2004 Oct 22; 22(31-32):4270-81. PubMed ID: 15474718
    [Abstract] [Full Text] [Related]

  • 27. Bordetella pertussis adenylate cyclase toxin: a vehicle to deliver CD8-positive T-cell epitopes into antigen-presenting cells.
    Guermonprez P, Fayolle C, Karimova G, Ullmann A, Leclerc C, Ladant D.
    Methods Enzymol; 2000 Oct 22; 326():527-42. PubMed ID: 11036662
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells.
    Simsova M, Sebo P, Leclerc C.
    Int J Med Microbiol; 2004 Apr 22; 293(7-8):571-6. PubMed ID: 15149033
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice.
    Orr B, Douce G, Baillie S, Parton R, Coote J.
    Vaccine; 2007 Jan 02; 25(1):64-71. PubMed ID: 16916566
    [Abstract] [Full Text] [Related]

  • 34. Plasmid DNA vaccines are effective in the absence of IFNgamma.
    Hassett DE, Zhang J, Whitton JL.
    Virology; 1999 Oct 10; 263(1):175-83. PubMed ID: 10544092
    [Abstract] [Full Text] [Related]

  • 35. Bordetella adenylate cyclase toxin: a unique combination of a pore-forming moiety with a cell-invading adenylate cyclase enzyme.
    Masin J, Osicka R, Bumba L, Sebo P.
    Pathog Dis; 2015 Nov 10; 73(8):ftv075. PubMed ID: 26391732
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus.
    Whitton JL, Gebhard JR, Lewicki H, Tishon A, Oldstone MB.
    J Virol; 1988 Mar 10; 62(3):687-95. PubMed ID: 2448497
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.